Literature DB >> 6792542

Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats.

A I Faden, T P Jacobs, J W Holaday.   

Abstract

Naloxone treatment improves neurologic outcome after experimentally induced spinal trauma, but this opiate-receptor antagonist may increase post-traumatic pain. In contrast, thyrotropin-releasing hormone appears to act in vivo as a partial physiologic opiate antagonist that spares analgesic systems; this activity prompted us to evaluate its effect in spinal injury. Cervical-spine trauma was produced in anesthetized cats by the Allen method. Six animals each received thyrotropin-releasing hormone, saline, or dexamethasone as an intravenous infusion over four hours, beginning one hour after injury. Neurologic recovery was significantly better after treatment with thyrotropin-releasing hormone than after saline or dexamethasone (P less than 0.01): at six weeks, the average animal given thyrotropin-releasing hormone was normal, whereas average control animals had marked spasticity. The beneficial effect of thyrotropin-releasing hormone in experimental spinal injury and its lack of effect on nociception indicate that it may have unique therapeutic potential in spinal trauma in human beings.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6792542     DOI: 10.1056/NEJM198110293051806

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  20 in total

Review 1.  The effects of ante- and postnatal hypoxia on the central nervous system and their correction with peptide hormones.

Authors:  M V Maslova; A S Maklakova; N A Sokolova; I P Ashmarin; E N Goncharenko; Ya V Krushinskaya
Journal:  Neurosci Behav Physiol       Date:  2003-07

Review 2.  Neuroprotection and acute spinal cord injury: a reappraisal.

Authors:  Edward D Hall; Joe E Springer
Journal:  NeuroRx       Date:  2004-01

3.  The effects of chronic alpha-tocopherol administration on lipid peroxidation in an experimental model of acute spinal cord injury.

Authors:  M Bozbuğa; N Izgi; A Canbolat
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

4.  Effect of low intravenous doses of TRH, acid-TRH and cyclo(His-Pro) on cerebral and peripheral blood flows.

Authors:  L O Koskinen
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

5.  Thyrotropin-releasing hormone (TRH) counteracts neuronal damage induced by a substance P antagonist.

Authors:  J Freedman; T Hökfelt; G Jonsson; C Post
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

6.  Proceedings of the British Pharmacological Society. Bristol, 5-7th April. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

7.  Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormone.

Authors:  J Freedman; T Hökfelt; C Post; E Brodin; E Sundström; G Jonsson; L Terenius; S Leander; J A Fischer; A Verhofstad
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

8.  Protirelin tartrate (TRH-T) in upper motoneuron syndrome: a controlled neurophysiological and clinical study.

Authors:  C Civardi; P Naldi; R Cantello; M Gianelli; R Mutani
Journal:  Ital J Neurol Sci       Date:  1994-11

9.  Multiple opioid receptors in endotoxic shock: evidence for delta involvement and mu-delta interactions in vivo.

Authors:  R D'Amato; J W Holaday
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  Methamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatum.

Authors:  Jean Lud Cadet; Michael T McCoy; Ning Sheng Cai; Irina N Krasnova; Bruce Ladenheim; Genevieve Beauvais; Natascha Wilson; William Wood; Kevin G Becker; Amber B Hodges
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.